ÂÜÀòÂÒÂ×

Johnny Zou is a Managing Director at Primavera Capital Group since June 2013. In addition to this role, Johnny Zou serves as a Board Member for Accutar Biotech, Accession Therapeutics Limited, and Snipd, contributing to the strategic direction of these organizations. As a Board Observer, Johnny Zou is involved with Xbiome, P12, and YOGO ROBOT, providing insights and governance. Furthermore, Johnny Zou holds the position of Board Director at ZAP Surgical Systems, Inc. and has made investments in Noah Medical and Hex Trust. Educated at Yale University with a Bachelor of Arts in History and at The London School of Economics with a Master's in Economic History, Johnny Zou has a strong academic foundation.